Search results
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 2 days agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
No, study didn't blame COVID-19 vaccines for excess pandemic deaths | Fact check
USA Today· 4 days agoA June 5 Facebook post (direct link, archive link) claims a new study has revealed alarming news...
Trump’s Anti-Vaccine Problem
New York Times· 1 day agoFour years later, a different aspect of his handling of the pandemic has emerged as a sensitive subject with another slice of the electorate: his own...
Combined flu and Covid vaccine from Moderna shows positive results
dpa international via Yahoo News· 5 days agoA combined flu and Covid vaccine from Moderna provokes a higher immune response than separate single...
Combined mRNA COVID-flu vaccine shows promise in Moderna trial
Semafor via Yahoo News· 4 days agoCOVID-19 vaccines were the first to use mRNA technology in the wild. The vaccines use a molecule...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 3 days agoHere's what we know about the newest vaccines so far. The Food and Drug Administration on Friday...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 22 hours agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 2 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
L.A. County COVID cases, hospitalizations rise amid FLiRT variants summer uptick
Los Angeles Times· 14 hours agoLos Angeles County’s COVID cases and hospitalizations are continuing to increase as a new subvariant...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...